Used as a key intermediate in the synthesis of lenalidomide, a pharmaceutical agent employed in the treatment of multiple myeloma and certain types of myelodysplastic syndromes. Its structure supports the formation of biologically active derivatives that modulate the immune system and inhibit tumor angiogenesis. Due to its functional groups, it is also utilized in research for developing novel cereblon-targeting compounds with potential applications in oncology and inflammatory diseases.